Self-efficacy for managing hypertension and comorbid conditions

doi:10.5494/wjh.v9.i3.30

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10932)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

538

WORD

288

HTML

6218

Figures (1-2)

692

Tables (1-4)

744

Sum=8480

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1106

Download

1346

Sum=2452

Dec 12, 2019 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hypertens. Dec 12, 2019; 9(3): 30-41
Published online Dec 12, 2019. doi: 10.5494/wjh.v9.i3.30

Table 3 Average T_clin scores in patient reported outcomes measurement information system self-efficacy for managing chronic conditions measures domains (mean ± SD)

Domains	Hypertension	Non-hypertension
SE-DA¹	49.2 ± 8.87	51.1 ± 9.85
SE-EM²	50.4 ± 9.54	49.7 ± 10
SE-MT³	49.4 ± 8.82	49.8 ± 9.83
SE-SS⁴	50 ± 9.22	49.6 ± 9.75
SE-SX⁵	49.8 ± 9.14	49.9 ± 9.87

¹Managing daily activities;

²Managing emotions;

³Managing medications and treatments;

⁴Managing social interactions;

⁵Managing symptoms.

Citation: Lee MJ, Romero S, Jia H, Velozo CA, Gruber-Baldini AL, Shulman LM. Self-efficacy for managing hypertension and comorbid conditions. World J Hypertens 2019; 9(3): 30-41
URL: https://www.wjgnet.com/2220-3168/full/v9/i3/30.htm
DOI: https://dx.doi.org/10.5494/wjh.v9.i3.30